Cypress Equities Real Estate Investment Management, which owns Lloyd Center in Portland, Ore., is investing $50 million in a renovation of the property to return it to its "cool" and trendy state. The property will have a retro vibe.
Acadia Realty Trust has reportedly signed a contract to acquire a 3,000-square-foot ground-floor retail co-op in New York City's Soho neighborhood for $50 million. In a separate transaction, the REIT recently partnered in the acquisition of Eden Square, a 235,508-square-foot retail center in Bear, Del.
Hyperion Therapeutics intends to raise $50 million through a public offering. The company will use the proceeds to fund a late-stage trial of its newly approved urea cycle disorder drug Ravicti in patients with hepatic encephalopathy and a 10-year followup study.
KaloBios Pharmaceuticals could raise about $50 million from selling 3.85 million shares in an initial public offering. The company specializes in developing Humaneered antibodies, which are human antibodies based on nonhuman antibodies for the treatment of cancer and respiratory diseases.